Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-05-10, Stock:LLY, The news for the past five days is as follows:
2018-05-03: NEWS1: Health Secretary Alex Azar: ‘Bold action is on the way’ for drug prices.NEWS2: United Therapeutics (UTHR) Q1 Earnings Rise, Sales Drop Q/Q.NEWS3: United Therapeutics (UTHR) Q1 Earnings Rise, Sales Drop Q/Q.NEWS4: Teva Stock Rises on Strong 1Q18 Results, Outlook Up.NEWS5: Olumiant: A Key Drug in Rheumatoid Arthritis Indications.NEWS6: Label Expansion May Boost Trulicity’s Revenues.NEWS7: Factors that Could Drive Trulicity’s Revenue Growth in 2018.
2018-05-04: NEWS1: Allergan’s US Specialized Therapeutics Segment in 1Q18.NEWS2: Allergan’s Business Segments in 1Q18.NEWS3: Top Ranked Growth Stocks to Buy for May 4th.NEWS4: Top Ranked Growth Stocks to Buy for May 4th.NEWS5: Q1 Earnings Drag Pharma ETFs Down.NEWS6: Q1 Earnings Drag Pharma ETFs Down.NEWS7: Is Trump Willing To Do What It Takes To Reduce High Prescription Drug Prices?.NEWS8: Q1 Earnings Drag Pharma ETFs Down.NEWS9: Top Ranked Growth Stocks to Buy for May 4th.NEWS10: Prolia Revenue Grew 16% in 1Q18.NEWS11: See what the IHS Markit Score report has to say about Eli Lilly And Co..NEWS12: Eli Lilly Shares Seen Rising 18% as Profits Surge.
2018-05-07: NEWS1: Lilly Declares Second-Quarter 2018 Dividend.NEWS2: What's in Store for Radius Health (RDUS) in Q1 Earnings?.NEWS3: What's in Store for Radius Health (RDUS) in Q1 Earnings?.NEWS4: Alimta: An Emerging Drug to Treat Lung Cancer.NEWS5: Allergan’s Valuations after Its 1Q18 Earnings.NEWS6: Verzenio: Major CDK4/6 Inhibitor in the Future.NEWS7: Taltz: Therapy for Psoriasis Indication.NEWS8: How Celgene Performed in 1Q18.NEWS9: See what the IHS Markit Score report has to say about Eli Lilly And Co..NEWS10: Allergan’s US General Medicines Segment in 1Q18.
2018-05-08: NEWS1: Daily Dividend Report: BAX, JLL, JCOM, DK, LLY.NEWS2: Daily Dividend Report: BAX, JLL, JCOM, DK, LLY.NEWS3: Keytruda: Merck’s Immuno-Oncology Blockbuster Drug in 1Q18.NEWS4: Merck’s Segment-Wise Performance in 1Q18.NEWS5: Will Elanco’s Top-Line Growth Return in 2018?.NEWS6: Label Expansion Might Boost Cyramza’s Revenues in 2018.
2018-05-09: NEWS1: AVEO Pharmaceuticals (AVEO) Q1 Loss Wider Than Expected.NEWS2: AVEO Pharmaceuticals (AVEO) Q1 Loss Wider Than Expected.NEWS3: How Did Abraxane and Celgene’s Other Drugs Perform in 1Q18?.

Answer: Rise